Pancreatic cancer (PC) is a fatal disease that has a poor 5-year survival rate. The poor
prognosis can be attributed to both troublesome detections at the initial stage, which makes …

Cancer exerts a multitude of effects on metabolism, including the reprogramming of cellular
metabolic pathways and alterations in metabolites that facilitate inappropriate proliferation of …

Over a billion people across the world experience a high rate of missed disease diagnosis,
an issue that highlights the need for diagnostic tools showing increased accuracy and …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a poor
prognosis and limited therapeutic options. Research on the tumor microenvironment (TME) …

In vitro diagnosis (IVD) is one vital component of medical tests that detects biological
samples of tissues or bio‐fluids. Recently, mass spectrometry and spectroscopy have been …

As one of the most influential industries in public health and the global economy, the
pharmaceutical industry is facing multiple challenges in drug research, development and …

Pancreatic cancer (PC) has one of the highest fatality rates and the currently available
therapeutic options are not sufficient to improve its overall poor prognosis. In addition to …

Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic malignancy for which there
are currently no effective anti-metastatic therapies. Herein, we employed single-cell RNA …

Metabolomics is a fast-developing technique used in biomedical researches focusing on
pathological mechanism illustration or novel biomarker development for diseases. The …

There is a wide variety of autoimmune diseases (ADs) with complex pathogenesis and their
accurate diagnosis is difficult to achieve because of their vague symptoms. Metabolomics …